Guardant Health, Inc. (BMV:GH)
Mexico flag Mexico · Delayed Price · Currency is MXN
820.00
-23.00 (-2.73%)
At close: May 12, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Precision Oncology Testing
687.94M
Log In
Log In
Log In
Log In
Upgrade
Precision Oncology Testing Growth
-
Log In
Log In
Log In
Log In
Upgrade
Development Services and Other
51.08M
Log In
Log In
Log In
Log In
Upgrade
Development Services and Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Gross Income by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Precision Oncology Testing Gross Profit
427.36M
Log In
Log In
Log In
Log In
Upgrade
Precision Oncology Testing Gross Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade
Development Services and Other Gross Profit
21.86M
Log In
Log In
Log In
Log In
Upgrade
Development Services and Other Gross Profit Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
United States
697.16M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
29.82%
Log In
Log In
Log In
Log In
Upgrade
International
41.85M
Log In
Log In
Log In
Log In
Upgrade
International Growth
4.67%
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Clinical Test Sales Volume
206.70K
Log In
Log In
Log In
Log In
Upgrade
Clinical Test Sales Volume Growth
25.80%
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical Test Sales Volume
40.50K
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical Test Sales Volume Growth
-
Log In
Log In
Log In
Log In
Upgrade